<DOC>
	<DOCNO>NCT02708966</DOCNO>
	<brief_summary>Prediabetes ( PD ) define state glucose level normal enough meet criterion diagnosis type 2 diabetes ( T2D ) . PD present impaired fasting glucose ( IFG ) , impair glucose tolerance ( IGT ) glycated hemoglobin A1c ( A1C ) alter . The International Diabetes Federation ( IDF ) report 2013 prevalence IGT 6.9 % equivalent approximately 316 million individual IGT , expect 2035 number increase 417 million people affect . Many hypoglycemic effect attribute Gymnema sylvestre report , include : increase insulin secretion , regeneration pancreatic islet cell , increase glucose utilization various way inhibition glucose uptake intestine .</brief_summary>
	<brief_title>Effect Gymnema Sylvestre Patients With Impaired Glucose Tolerance .</brief_title>
	<detailed_description>The target evaluate effect administration Gymnema Sylvestre glycemic control , insulin secretion insulin sensibility patient IGT . The investigator conduct double-blind trial , randomize , placebo control group , group 12 female male patient , 30 59 year old IGT ( 2-h value oral glucose tolerance test [ OGTT ] 140 mg / dL 199 mg / dL ) , Body Mass Index ( BMI ) 25 34.9 kg / m2 . Randomization determine receive intervention 9-week trial ( Gymnema Sylvestre capsule , 300 mg 2 time daily first bite breakfast dinner homologated placebo capsule ) . The clinical finding laboratory test include metabolic profile biosafety , make baseline week 9 . Body weight , body fat , BMI blood pressure determine initial final visit . Adverse event adherence treatment document . Statistical analysis : Mann-Whitney U test , Wilcoxon Fisher exact test . It consider significance p &lt; 0.05 .</detailed_description>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>BMI : 25.034.99 kg / m2 . Diagnosis IGT ( 2hOGTT Values 140mg / dl 199mg / dl . ) Written informed consent . body weight stable last 3 month . Women follicular phase menstrual cycle ( day 3 8 cycle ) time laboratory test . Women contemplate get pregnant within next 6 month . Women pregnant breastfeeding . Physical mental disability make impossible perform intervention . Diagnosis hypertension heart failure . Smokers . Untreated thyroid disease . Consumption oral agent medication supplement proven property modify behavior glucose lipid ( oral hypoglycemic agent , insulin , lipidlowering ) . Diagnosis liver disease elevation twice upper normal value liver enzymes . Diagnosis renal disease creatinine &gt; 1.5 mg / dl . Diagnosis Type 2 Diabetes Mellitus ( T2DM ) Fasting glucose ≥ 126 mg / dL and/or 2hOGTT ≥ 200 mg / dL and/or A1C ≥ 6.5 % . Total Cholesterol ≥ 280 mg/dL . Triglycerides ≥ 300 mg/dL . Known allergy calcine magnesia Gymnema sylvestre .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Gymnema Sylvestre</keyword>
	<keyword>Glycemic control</keyword>
</DOC>